Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Ka Young Kim, Ki Young Shin, Keun‐A Chang
Cells (2023) Vol. 12, Iss. 9, pp. 1309-1309
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer’s Disease
Sujun Jiang, Guoen Cai, Zhimin Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 18, pp. 11753-11768
Closed Access | Times Cited: 25
Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathy
Jean Paul Chadarevian, Jonathan Hasselmann, Alina Lahian, et al.
Neuron (2024) Vol. 112, Iss. 16, pp. 2686-2707.e8
Open Access | Times Cited: 22
Neuroinflammation in Alzheimer disease
Wiesje M. van der Flier, Wiesje M. van der Flier, Frank Jessen, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 14
Challenges in the practical implementation of blood biomarkers for Alzheimer’s disease
Michael Schöll, Inge M.W. Verberk, Marta del Campo, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 10, pp. 100630-100630
Open Access | Times Cited: 12
Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi‐ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort
Yian Gu, Lawrence S. Honig, Min Suk Kang, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 3, pp. 1988-1999
Open Access | Times Cited: 11
Longitudinal plasma phosphorylated‐tau217 and other related biomarkers in a non‐demented Alzheimer's risk‐enhanced sample
Lianlian Du, Rebecca E. Langhough, Rachael E Wilson, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6183-6204
Open Access | Times Cited: 10
Central autonomic network dysfunction and plasma Alzheimer’s disease biomarkers in older adults
Trevor Lohman, Arunima Kapoor, Allison C Engstrom, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
Geetika Nehra, Bryan Maloney, Rebecca Smith, et al.
Fluids and Barriers of the CNS (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Eunshil Lee, Yongmin Chang
Cells (2025) Vol. 14, Iss. 3, pp. 168-168
Open Access | Times Cited: 1
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection
Eugene Duff, Henrik Zetterberg, Amanda Heslegrave, et al.
Nature Medicine (2025)
Open Access | Times Cited: 1
Phenyl salicylate induces neurotoxicity and early Alzheimer's disease-like symptoms through ndrg1-regulated myelin damage, increasing bace1 in zebrafish
Siyu Liu, Xiao‐Mei Li, Shuping Jiao, et al.
The Science of The Total Environment (2025) Vol. 965, pp. 178664-178664
Closed Access | Times Cited: 1
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Decreased water exchange rate across the blood–brain barrier throughout the Alzheimer's disease continuum: Evidence from Chinese data
Guanqun Chen, Hui Li, Xingfeng Shao, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.
Carlos Cruchaga, Muhammad Ali, Yuanyuan Shen, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 6
Repositioning of baricitinib for management of memory impairment in ovariectomized/D-galactose treated rats: A potential role of JAK2/STAT3-PI3K/AKT/mTOR signaling pathway
Merhan O. Hindam, Lamiaa A. Ahmed, Nesrine S. El Sayed, et al.
Life Sciences (2024) Vol. 351, pp. 122838-122838
Closed Access | Times Cited: 6
Circulating small extracellular vesicles in Alzheimer’s disease: a case–control study of neuro-inflammation and synaptic dysfunction
Rishabh Singh, Sanskriti Rai, Prahalad Singh Bharti, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
A systematic review of the neuropathology and memory decline induced by monosodium glutamate in the Alzheimer’s disease-like animal model
Singh S. Ankul, Lakshmi Chandran, Anuragh Singh, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
The seeds of its regulation: Natural antisense transcripts as single-gene control switches in neurodegenerative disorders
Debomoy K. Lahiri, Bryan Maloney, Ruizhi Wang, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102336-102336
Closed Access | Times Cited: 5
Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer’s disease research
Pasindu Hansana Singhaarachchi, Péter Antal, Frédéric Calon, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 162, pp. 105724-105724
Open Access | Times Cited: 5
Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infection
Jonathan A. B. Villareal, Tim Bathe, Gabriela P. Hery, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
The impact of physical exercise on neuroinflammation mechanism in Alzheimer’s disease
Junhui Hu, Baiqing Huang, Kang Chen
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 5
The Evaluation of Clinical Applications for the Detection of the Alzheimer’s Disease Biomarker GFAP
Göksu Ozcelikay, Leyla Karadurmuş, Ahmet Çetinkaya, et al.
Critical Reviews in Analytical Chemistry (2024), pp. 1-12
Closed Access | Times Cited: 5
Blood levels of cytokines highlight the role of inflammation in Alzheimer´s disease
Lorenzo Campanelli, Pablo Galeano, Federico Ariel Prestia, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e41725-e41725
Closed Access
Captopril attenuates oxidative stress and neuroinflammation implicated in cisplatin-induced cognitive deficits in rats
Fatma Mostafa, Eman M. Mantawy, Riham S. Said, et al.
Psychopharmacology (2025)
Open Access
Lab-on-chip arrays for diagnostic applications
Fatemeh Mohammadi, Hamed Zahraee, Zahra Khoshbin, et al.
Elsevier eBooks (2025), pp. 455-478
Closed Access
Page 1 - Next Page

Scroll to top